| Announce Date | 12/18/2025 |
| EPS Normalized Actual | $4.82 (Beat by $0.7) |
| EPS GAAP Actual | $4.82 (Beat by $0.7) |
| Revenue Actual | $23.469B |
| Revenue Surprise | Beat by $23469M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| May 2030 | 34.18515 | 10.8 | 32.83015 | 35.90236 | 2 |
| May 2029 | 35.3379 | 10.45 | 33.62465 | 36.42168 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 3.93 | 3.93 | 23.469B | 6.4% | 23469M |
| FQ3 2025 (Aug 2025) | 3.48 | 3.48 | 22.244B | 2.99% | 22244M |
| FQ2 2025 (May 2025) | 6.88 | 6.88 | 22.22B | 0.5% | 22220M |
| FQ1 2025 (Feb 2025) | 3.79 | 3.79 | 22.16B | 1.9% | 22160M |
| FQ4 2024 (Nov 2024) | 3.07 | 3.07 | 21.967B | -0.9% | 21967M |
| FQ3 2024 (Aug 2024) | 3.21 | 3.21 | 21.579B | -0.47% | 21579M |
| FQ2 2024 (May 2024) | 0 | 0 | 22.109B | 0.81% | 22109M |
| FQ1 2024 (Feb 2024) | 3.55 | 3.55 | 21.738B | -1.98% | 21738M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2030 (May 2030) | 8.9777 | -- | 8.80361 | 9.10831 | 9 |
| FQ1 2030 (Feb 2030) | 6.8332 | -- | 6.70069 | 6.93261 | 7 |
| FQ4 2029 (Nov 2029) | 6.3037 | -- | 6.05724 | 6.4694 | 6 |
| FQ3 2029 (Aug 2029) | 5.8557 | -- | 5.62676 | 6.00962 | 6 |
| FQ2 2029 (May 2029) | 9.33 | -- | 8.96407 | 9.59525 | 9 |
| FQ1 2029 (Feb 2029) | 5.8526 | -- | 5.62378 | 6.00644 | 12 |
| FQ4 2028 (Nov 2028) | 6.8764 | -- | 6.6067 | 7.07189 | 10 |
| FQ3 2028 (Aug 2028) | 5.7219 | -- | 5.59746 | 5.87392 | 11 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2030 (May 2030) | 27.08B | -- | 26.68B | 27.39B | 10 |
| FQ1 2030 (Feb 2030) | 27.4B | -- | 26.99B | 27.7B | 8 |
| FQ4 2029 (Nov 2029) | 26.97B | -- | 26.16B | 27.52B | 6 |
| FQ3 2029 (Aug 2029) | 26.31B | -- | 25.51B | 26.84B | 7 |
| FQ2 2029 (May 2029) | 26.2B | -- | 25.41B | 26.77B | 9 |
| FQ1 2029 (Feb 2029) | 26.19B | -- | 25.4B | 26.72B | 6 |
| FQ4 2028 (Nov 2028) | 25.88B | -- | 25.1B | 26.45B | 13 |
| FQ3 2028 (Aug 2028) | 23.98B | -- | 23.58B | 24.47B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 3.93 | 3.93 | 100% | |
| FQ3 2025 (Aug 2025) | 3.48 | 3.48 | 100% | |
| FQ2 2025 (May 2025) | 6.88 | 6.88 | 100% | |
| FQ1 2025 (Feb 2025) | 3.79 | 3.79 | 100% | |
| FQ4 2024 (Nov 2024) | 3.07 | 3.07 | 100% | |
| FQ3 2024 (Aug 2024) | 3.21 | 3.21 | 100% | |
| FQ2 2024 (May 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Feb 2024) | 3.55 | 3.55 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $23.47B | $23469M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $22.24B | $22244M | 100% |
| FQ2 2025 (May 2025) | $0B | $22.22B | $22220M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $22.16B | $22160M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $21.97B | $21967M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $21.58B | $21579M | 100% |
| FQ2 2024 (May 2024) | $0B | $22.11B | $22109M | 100% |
| FQ1 2024 (Feb 2024) | $0B | $21.74B | $21738M | 100% |